SCHEMBL9977

SCHEMBL9977

c1cnncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29501299 1.00 — —
Pyrazine SCHEMBL2538511 0.96 — —
Hydrochloric Acid SCHEMBL8799455 0.96 — —
SCHEMBL31164666 0.96 — —
SCHEMBL28122131 0.96 — —
SCHEMBL1685846 0.93 — —
Formaldehyde SCHEMBL27467279 0.89 — —
Pyridazine SCHEMBL28033129 0.89 TSHR (0.33) —
SCHEMBL28591258 0.89 — —
SCHEMBL1905671 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 40058 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122059895-A Preparation method of 1,2, 4-triazine derivative 江西同和药业股份有限公司 2026-05-19 — — CN claimed
WO-2026098683-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF 盛睿泽华医药科技(苏州)有限公司 2026-05-15 — — WO claimed
US-20260130106-A1 PHOTOELECTRIC DEVICE AND PREPARATION METHOD THEREFOR TCL TECHNOLOGY GROUP CORPORATION (CN) 2026-05-07 — — US claimed
EP-4045036-B1 HETEROARYL-BIPHENYL AMIDES FOR THE TREATMENT OF PD-L1 DISEASES CHEMOCENTRYX INC (US) 2026-03-04 — — EP claimed
US-20260048076-A1 METHODS FOR DECREASING OR INHIBITING HUMAN L1 RETROTRANSPOSON RNA AND COMPOSITIONS FOR USE THEREIN ALTOS LABS, INC. (US) 2026-02-19 — — US claimed
US-20260048156-A1 FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS Atoms for Cure GmbH (DE) 2026-02-19 — — US claimed
EP-4045037-B1 HETEROARYL-BIPHENYL AMINES FOR THE TREATMENT OF PD-L1 DISEASES CHEMOCENTRYX INC (US) 2026-01-28 — — EP claimed
US-12497383-B2 Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases CHEMOCENTRYX, INC. (US) 2025-12-16 — — US claimed
US-20250289788-A1 HALOALKYL SULFONANILIDE COMPOUND AND HERBICIDE CONTAINING THE SAME SDS BIOTECH K.K. (JP) 2025-09-18 — — US claimed
EP-4608801-A1 ANTICANCER DRUG CONJUGATES Ariel Scientific Innovations Ltd. (IL) 2025-09-03 — — EP claimed
EP-0088109-A1 ANTIINFLAMMATORY SUBSTITUTED-1,2,4-TRIAZOLO(4,3-b)-1,2,4-TRIAZINES DIAMOND SHAMROCK CORPORATION (US) 1983-09-14 — — EP claimed
WO-1983000864-A1 ANTIINFLAMMATORY SUBSTITUTED-1,2,4-TRIAZOLOAD4,3-bBD-1,2,4-TRIAZINES DIAMOND SHAMROCK CORP (US) 1983-03-17 — — WO claimed
EP-0067508-A1 Amidine derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-12-22 — — EP claimed
EP-0060697-A1 Heterocyclic derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-09-22 — — EP claimed
EP-0033163-A2 3,5-Dioxo-2,3,4,5-tetrahydro-1,2,4-triazine compounds, composition containing them, their use as insecticides and acaricides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-08-05 — — EP claimed
EP-0030038-A1 1,2,4-Triazine derivatives, process for their production and pharmaceutical composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-06-10 — — EP claimed
US-4159251-A Ultrafiltration membranes based on heteroaromatic polymers PHARMACO, INC. (US) 1979-06-26 — — US claimed
US-4154831-A Cephalosporins having an α-acylaminoacetic acid side chain CIBA-GEIGY CORPORATION (US) 1979-05-15 — — US claimed
US-4154929-A CHELATOR AND INDICATOR OF FERROUS IONS AMERICAN MONITOR CORPORATION (US) 1979-05-15 — — US claimed
US-4041161-A ANTIBIOTICS CIBA-GEIGY CORPORATION (US) 1977-08-09 — — US claimed
Send feedback